These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26645027)

  • 1. The pattern and risk factors associated with adverse drug reactions induced by Reteplase in patients with acute ST-elevation myocardial infarction: The first report from Iranian population.
    Aslanabadi N; Safaie N; Shadfar F; Taban-Sadeghi MR; Feizpour H; Mashayekhi SO; Hamishehkar H; Aghdam NK; Dousti S; Namdar H; Entezari-Maleki T
    J Res Pharm Pract; 2015; 4(4):206-11. PubMed ID: 26645027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Streptokinase Therapy Complications and its Associated Risk Factors in Patients with Acute ST Elevation Myocardial Infarction.
    Aslanabadi N; Safaie N; Talebi F; Dousti S; Entezari-Maleki T
    Iran J Pharm Res; 2018; 17(Suppl):53-63. PubMed ID: 29796029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-Reteplase Evaluation of Clinical Safety & Efficacy in Indian Patients (Precise-In Study).
    Singh RK; Trailokya A; Naik MM
    J Assoc Physicians India; 2015 Apr; 63(4):30, 32-5. PubMed ID: 26591167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study.
    Angamo MT; Curtain CM; Chalmers L; Yilma D; Bereznicki L
    PLoS One; 2017; 12(10):e0186631. PubMed ID: 29036230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy).
    Cura FA; Roffi M; Pasca N; Wolski KE; Lincoff AM; Topol EJ; Lauer MS;
    Am J Cardiol; 2004 Oct; 94(7):859-63. PubMed ID: 15464665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and timing of prehospital administration of reteplase in patients with acute myocardial infarction.
    Rosenberg DG; Levin E; Lausell A; Brown A; Gardner J; Perez E; Veenendaal M; Ong YS; Gunn M
    J Thromb Thrombolysis; 2002 Jun; 13(3):147-53. PubMed ID: 12355031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause.
    Passarelli MC; Jacob-Filho W; Figueras A
    Drugs Aging; 2005; 22(9):767-77. PubMed ID: 16156680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Adverse Drug Reaction in the Medical Wards of a Teaching Hospital: A Prospective Observational Cohort Study.
    Peter JV; Varghese GH; Alexander H; Tom NR; Swethalekshmi V; Truman C; Kumar TR; Sivakumar T
    Curr Drug Saf; 2016; 11(2):164-71. PubMed ID: 26916785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
    Topol EJ;
    Lancet; 2001 Jun; 357(9272):1905-14. PubMed ID: 11425410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality from adverse drug reaction-related hospitalizations in south-west Ethiopia: A cross-sectional study.
    Angamo MT; Chalmers L; Curtain CM; Yilma D; Bereznicki L
    J Clin Pharm Ther; 2018 Dec; 43(6):790-798. PubMed ID: 29722039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reactions in hospitalized cardiac patients: characteristics and risk factors.
    Mugosa S; Bukumirić Z; Kovacević A; Bosković A; Protić D; Todorović Z
    Vojnosanit Pregl; 2015 Nov; 72(11):975-81. PubMed ID: 26731971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
    Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
    Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-infectives-induced adverse drug reactions in hospitalized patients.
    Gholami K; Parsa S; Shalviri G; Sharifzadeh M; Assasi N
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):501-6. PubMed ID: 15844215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Abciximab REteplase Stent Study in acute myocardial infarction (CARESS in AMI).
    Di Mario C; Bolognese L; Maillard L; Dudek D; Gambarati G; Manari A; Guiducci V; Patrizi G; Rusconi LC; Piovaccari G; Hibon AR; Belpomme V; Indolfi C; Olivari Z; Steffenino G; Zmudka K; Airoldi F; Panzarasa R; Flather M; Steg PG
    Am Heart J; 2004 Sep; 148(3):378-85. PubMed ID: 15389222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin specificity and procoagulant effect related to the kallikrein-contact phase system and to plasmin generation with double-bolus reteplase and front-loaded alteplase thrombolysis in acute myocardial infarction.
    Hoffmeister HM; Kastner C; Szabo S; Beyer ME; Helber U; Kazmaier S; Baumbach A; Wendel HP; Heller W
    Am J Cardiol; 2000 Aug; 86(3):263-8. PubMed ID: 10922430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of thrombolytic therapy using reteplase in cases with acute ST-segment elevation myocardial infarction: results from a multicenter clinical trial].
    Liu XY; Zhang Y; Li MW; Wang XP; Qi DD; Hao PY; Zhang H; Cheng QQ; Zhao LS; Gao CY; Hu DY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):766-770. PubMed ID: 27667274
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical characteristics and risk assessment of ST-segment elevation myocardial infarction patients of an Iranian referral center.
    Khalili H; Talasaz AH; Jenab Y; Salarifar M
    J Cardiovasc Med (Hagerstown); 2012 Nov; 13(11):708-15. PubMed ID: 22914305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, Characteristics and Factors Associated with Adverse Drug Reactions Among Hospitalized Patients.
    Mt M; Ss J; Plgc L; Tghk S
    Hosp Pharm; 2024 Aug; 59(4):489-497. PubMed ID: 38919759
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of reteplase with alteplase for acute myocardial infarction.
    Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators
    N Engl J Med; 1997 Oct; 337(16):1118-23. PubMed ID: 9340503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.